Contagion&reg Editorial Staff

The US Food and Drug Administration approved the first adjuvanted quadrivalent influenza vaccine for adults 65 years and older.

Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of February 16, 2020.

We’ve compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week:

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, explains some of the factors which underlie the cost of ID treatment.

Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, explains contemporary challenges facing ID clinicians individually and as a profession.

Mark Riddle, MD, DrPH, speaks to Contagion at ACG 2019 about the results of a study looking into microbiome changes associated with single-dose antibiotics for the treatment of traveler's diarrhea.

Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of February 9, 2020.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Jason Tokumoto, MD, explains the need to look beyond nonadherence and understand a patient with HIV as a complex person.

Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, discusses areas of unmet need and challenges ahead in the ID development economic landscape.

Jason Tokumoto, MD, discusses the evolution of HIV treatment.

Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of February 2, 2020.

We’ve compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week:

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Rebiotix has announced that it has completed enrollment of a phase 3 clinical trial for RBX2660.

Mark Riddle, MD, DrPH, speaks to Contagion about preventing drug resistance in people who acquire traveler's diarrhea.

The US Food and Drug Administration has authorized the use of a new diagnostic for 2019 novel coronavirus.

Andrea L. Cox, MD, PhD, discusses the implications of discovering that an experimental vaccine was not effective at preventing chronic hepatitis C virus.

The US Food and Drug Administration has approved Audenz, an adjuvanted influenza A H5N1 monovalent vaccine.

Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of January 26, 2020.

We’ve compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week:

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

As January comes to an end, we’re looking back at important infectious disease news from the past month.

Daniel Chastain, PharmD, BCIDP, discusses how antiretroviral stewardship might practically be implemented in the context that antimicrobial stewardship as a whole is often underdeveloped.

In this episode, our guests compare the West African Ebola outbreak to the ongoing outbreak in the Democratic Republic of the Congo.

Andrea L. Cox, MD, PhD, discusses some of the challenges in developing a vaccine for hepatitis C and details the results of a vaccine trial.

Max Brito, MD, MPH, explains the value of bringing safe, confidential, and non-stigmatizing HIV treatment to the community at IDWeek2019.

The US Food and Drug Administration has approved fidamoxicin for treatment of children aged 6 months up to 18 years with C diff infections.